SFL’s CEO to moderate panel discussion on MDR and combined products
SFL’s CEO Shayesteh Fürst-Ladani is moderating a panel discussion at the Medtech & Pharma Platform (MPP) Virtual Annual Conference (22-23 October 2020, online). The panel discussion is on the “Medical Devices Regulation (MDR) and Combined Products” (October 22, 1:30 pm CEST) and will address key MDR and combined products topics, including on clinical trials, regulatory pathways and article 117, with panelists from the European Commission, a national regulator, a Notified Body, and various pharma and medtech industry associations.
Shayesteh is President of the MPP Association and an expert in EU and US regulations including the EU MDR, having participated in reviewing and assessing the impact of legislation in these regions for both pharma and medical device products, as well as combined products with drug, device and software components. Furthermore, Shayesteh is a Lecturer in Regulatory Affairs at IFPMA/Kings College.
Shayesteh would be happy to have a 1-1 meeting with you via SFL’s company profile on the MPP2020 virtual conference platform, or you can contact SFL to arrange a call to discuss how SFL’s interdisciplinary teams, covering Medical Devices and Combination Products, Regulatory Affairs, Medical Affairs, Quality Assurance and Supply Chain, can support you to ensure your medical devices and combined products conform to all requirements under the MDR and IVDR.